Sunday, April 13, 2014 10:07:27 PM
http://au.ibtimes.com/articles/547915/20140414/alcoholism-addictions-biocorr-fda.htm#.U0tBbWS9Kc0
The misuse of prescription painkillers burdens the U.S. healthcare system with an estimated annual cost of $72 billion and prescription drug overdose deaths have more than quadrupled since 1999 and there are approximately 88,000 deaths linking to alcohol abuse each year in the United States, according to the Centers for Disease Control and Prevention (CDC).
Too much is always a bad thing with liquor and alcohol-laced drinks (Wiki Commons)
The company BioCorRx Inc. has announced the development a unique and highly effective treatment program to opioids and alcohol addiction that consist of two components.
The first component eliminates the physical cravings to drugs and alcohol by utilizing the drug Naltrexone implant, an opiate antagonist, administered by a trained licensed medical professional under local anesthetic.
It is administered to patients through a minimally invasive procedure where the Naltrexone implant is inserted beneath the skin of the lower abdominal area.
The BioCorRx, Inc.'s Naltrexone Implant is one of the only single-administration and long-acting implants used in the U.S. today. According to the chief operating officer of BioCorRx Inc., Brady Granier, any compound that is administered through injection or implants must be completely sterilized and free of contamination.
Administering implant as the delivery method for Naltrexone is an approved process bythe U.S. Food and Drug Administration (FDA).
The procedure acts by slowly releasing the drug into the body over the next several months in order to continue to eliminate the cravings for drugs and alcohol.
Since administering the implant is minimally invasive, the procedure is done outpatient and can be scheduled anytime.
Reportedly, patients experience miinimal to zero discomfort during the procedure and has returned to work the same day and within few hours after the drug has been implanted. Patients reported free from cravings of drug and alcohol and this is where the life coaching will begin which isthe second component of the program.
To contact the editor, e-mail: editor@ibtimes.com
Recent BICX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 12:42:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 09:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:59:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 08:47:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 08:25:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:15:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 04:37:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 07:55:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 11:38:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 09:01:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:56:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:50:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:38:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:30:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:40:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:05:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:04:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:04:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:03:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:03:08 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM